Products
Online Inquiry
Glycerophospho-N-palmitoyl ethanolamine
Cat. No.:
OB0626WX-2817
Appearance:
Crystalline solid
Purity:
≥95%
Identity:
Confirmed by NMR, TLC, and HPLC.
Size:
Add to basket
Product Overview
Description:
Glycerophospho-N-palmitoyl ethanolamine is the primary metabolic phospholipid precursor responsible for the generation of the endogenous lipid mediator palmitoyl ethanolamide. The downstream cleavage product functions as a potent anti-inflammatory agent across mammalian tissues, exerting its physiological effects through novel non-classical cannabinoid pathways independent of standard central cannabinoid receptors.
Synonyms:
Mono(2,3-dihydroxypropyl)-mono[2-[(1-oxohexadecyl)amino]ethyl]ester phosphoric acid; GP-NAE; GP-NPEA; 100575-09-5; 2,3-dihydroxypropyl 2-(hexadecanoylamino)ethyl hydrogen phosphate; 2,3-Dihydroxypropyl (2-palmitamidoethyl) hydrogen phosphate; 2,3-Dihydroxypropyl 2-hexadecanamidoethyl hydrogen phosphate; 2,3-Dihydroxypropyl 2-(palmitoylamino)ethyl hydrogen phosphate; Phosphoric acid, mono(2,3-dihydroxypropyl) mono[2-[(1-oxohexadecyl)amino]ethyl] ester
CAS No.:
100575-09-5
Compound CID:
53393933
Formula:
C21H44NO7P
Formula Weight:
453.6
Specification
Solubility in Other Solvents:
PBS: 5 mg/mL
Storage:
Storage at -20°C.
Applications:
Glycerophospho-N-palmitoyl ethanolamine serves as a reference compound for glycerophospholipid analysis and lipid metabolism research. It supports lipidomic annotation, quantitative analysis, and investigation of N-acyl ethanolamine-related lipid pathways.
